BioCryst Pharmaceuticals (MEX:BCRX) PB Ratio: (As of Jul. 02, 2026)


MEX:BCRX BioCryst Pharmaceuticals Inc MEX:BCRX
58 GF Score
Price MXN175.00
GF Value MXN229.77
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is BioCryst Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-02), BioCryst Pharmaceuticals's share price is MXN175.00. BioCryst Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2026 was MXN-158.17. Hence, BioCryst Pharmaceuticals's PB Ratio of today is .

The historical rank and industry rank for BioCryst Pharmaceuticals's PB Ratio or its related term are showing as below:

During the past 13 years, BioCryst Pharmaceuticals's highest PB Ratio was 422.86. The lowest was 4.32. And the median was 16.15.

MEX:BCRX's PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.91
* Ranked among companies with meaningful PB Ratio only.

During the past 3 years, the average Book Value Per Share Growth Rate was 29.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -43.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of BioCryst Pharmaceuticals was 127.70% per year. The lowest was -172.80% per year. And the median was -4.45% per year.

Back to Basics: PB Ratio


BioCryst Pharmaceuticals  (MEX:BCRX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


BioCryst Pharmaceuticals PB Ratio Related Terms


BioCryst Pharmaceuticals PB Ratio Historical Data

* Premium members only.

The historical data trend for BioCryst Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCryst Pharmaceuticals PB Ratio Chart

BioCryst Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioCryst Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MEX:BCRX vs SUPN, PBH, AMLX: PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioCryst Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioCryst Pharmaceuticals PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioCryst Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where BioCryst Pharmaceuticals's PB Ratio falls into.


MEX:BCRX
58GF Score
BioCryst Pharmaceuticals Inc MEX:BCRX
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioCryst Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

BioCryst Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=175.00/-158.167
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Is BioCryst Pharmaceuticals (MEX:BCRX) Overvalued in 2026?

Based on GuruFocus' analysis, BioCryst Pharmaceuticals stock appears to be undervalued. The current stock price of MXN175.00 is trading 23.8% below its estimated GF Value™ of MXN229.77. GuruFocus considers BioCryst Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for MEX:BCRX:

  • PB Ratio:
  • GF Value™: MXN229.77 vs. price of MXN175.00 (23.8% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the MEX:BCRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioCryst Pharmaceuticals Business Description

Other Exchanges BCRX:USABO1:Germany
Address 4505 Emperor Boulevard, Suite 200, Durham, NC, USA, 27703
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
58GF Score

Get the complete analysis for MEX:BCRX

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN175.00
Price
MXN229.77
GF Value